neuraxis.com (NRXS) - Long-Term Liabilities to Capital

The NeurAxis, Inc. (NRXS) business is protected by the humanitarian status of medicine, which minimizes external political risks. The dynamics of the long-term debt-to-equity ratio demonstrate the current vector of financial autonomy, where 0.02 expresses the latest level of the metric. The recurring sales model for consumables ensures a sustainable margin, while the defensive nature of neurostimulation guarantees stable demand regardless of economic cycles.

This ratio is calculated as long-term liabilities divided by equity, reflecting the impact of debt financing on total asset value. The metric measures the company's degree of dependence on creditors with maturities exceeding one year. For NeurAxis, Inc. (NRXS), such a capital structure is critical when outsourcing production and clinical trials. Analyzing long-term credit leverage allows for an assessment of the business model's resilience to rising interest rates.